Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGND) Non-Current Assets: 2010-2025

Historic Non-Current Assets for Ligand Pharmaceuticals (LGND) over the last 15 years, with Sep 2025 value amounting to $722.9 million.

  • Ligand Pharmaceuticals' Non-Current Assets rose 11.99% to $722.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $722.9 million, marking a year-over-year increase of 11.99%. This contributed to the annual value of $610.2 million for FY2024, which is 10.99% up from last year.
  • Latest data reveals that Ligand Pharmaceuticals reported Non-Current Assets of $722.9 million as of Q3 2025, which was up 21.35% from $595.7 million recorded in Q2 2025.
  • Ligand Pharmaceuticals' Non-Current Assets' 5-year high stood at $857.7 million during Q1 2021, with a 5-year trough of $481.4 million in Q2 2023.
  • For the 3-year period, Ligand Pharmaceuticals' Non-Current Assets averaged around $572.6 million, with its median value being $554.1 million (2024).
  • In the last 5 years, Ligand Pharmaceuticals' Non-Current Assets spiked by 141.47% in 2021 and then tumbled by 42.18% in 2023.
  • Over the past 5 years, Ligand Pharmaceuticals' Non-Current Assets (Quarterly) stood at $832.8 million in 2021, then slumped by 40.08% to $499.1 million in 2022, then increased by 10.16% to $549.8 million in 2023, then climbed by 10.99% to $610.2 million in 2024, then grew by 11.99% to $722.9 million in 2025.
  • Its Non-Current Assets stands at $722.9 million for Q3 2025, versus $595.7 million for Q2 2025 and $596.1 million for Q1 2025.